SFX by Ex Libris Inc.

Title:	IL-10 alters prolactin receptor activity emulating that during breast cancer
Source:	Cytokine [1043-4666] Paul, Sonali yr:2010

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Heckel, Mark C. "Human breast tumor cells express IL-10 and IL-12p40 transcripts and proteins, but do not produce IL-12p70." Cellular immunology 266.2 (2011): 143-153.
description	2.	Fernandez, I. "Prolactin and human tumorogenesis." Journal of neuroendocrinology 22.7 (2010): 771-777.
description	3.	Engel, M A. "Anticancer Properties of the IL-12 Family - Focus on Colorectal Cancer." Current Medicinal Chemistry 17.29 (2010): 3303-3308.
description	4.	Bernichtein, S. "New Concepts in Prolactin Biology." The Journal of endocrinology 206.1 (2010): 1-11.
description	5.	Dias, S. "IL-12 regulates VEGF and MMPs in a murine breast cancer model." International journal of cancer (1998): 361-365.
description	6.	Gomez-Sanchez, C. "Hyperprolactinemia in systemic lupus erythematosus: association with disease activity." The American journal of the medical sciences 303.4 (1992): 222-6.
description	7.	Langenheim, S. "Combination therapy using three novel prolactin receptor antagonist-based fusion proteins effectively inhibits tumor recurrence and metastasis in HER2/neu transgenic mice." International journal of oncology 34.4 (2009): 1139-46.
description	8.	Tworoger, S. "A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer." Journal of clinical oncology 25.12 (2007): 1482-1488.
description	9.	Clevenger, C. "From bench to bedside: Future potential for the translation of prolactin inhibitors as breast cancer therapeutics." Journal of Mammary Gland Biology and Neoplasia 13.1 (2008): 147-156.
description	10.	Holtkamp, W. "Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer." International journal of cancer 34.3 (1984): 323-8.
description	11.	Randolph, J. "Elevated early follicular gonadotropin levels in women with unexplained infertility do not provide evidence for disordered gonadotropin-releasing hormone secretion as assessed by luteinizing hormone pulse characteristics." Fertility and sterility 80.2 (2003): 320-327.
description	12.	Kitamura, Y. "Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide-induced lung injury in mice." American journal of respiratory and critical care medicine (2001): 762-9.
description	13.	Clevenger, C V V. "Prolactin as an autocrine/paracrine factor in breast tissue." Journal of Mammary Gland Biology and Neoplasia 2.1 (1996): 59-68.
description	14.	Reichenbach, A. "Muller cells in the healthy and diseased retina." Progress in Retinal and Eye Research 25.4 (2006): 397-424.
description	15.	Hankinson, S E E. "Plasma prolactin levels and subsequent risk of breast cancer in postmenopausal women." Journal of the National Cancer Institute 91.7: 629-634.
description	16.	Molitch, Mark E E. "Dopamine resistance of prolactinomas." Pituitary 6.1 (2003): 19-27.
description	17.	Begic, L. "Interleukin 13 expression in the primary breast cancer tumour tissue." Biochemia medica 21.2 (2011): 131-138.
description	18.	Pinkhasov, J. "Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model." Cancer immunology and immunotherapy 59.12 (2010): 1801-1811.
description	19.	Clevenger, Charles V V. "Role of prolactin/prolactin receptor signaling in human breast cancer." Breast disease 18.-1 (2003): 75-86.
description	20.	Tworoger, S. "Prolactin and breast cancer etiology: An epidemiologic perspective." Journal of Mammary Gland Biology and Neoplasia 13.1 (2008): 41-53.